238 results on '"Jastreboff, A. M."'
Search Results
2. Parent Stress and Trauma, Autonomic Responses, and Negative Child Behaviors
3. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
4. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
5. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
6. Association between specific types of parent stressors and fast-food consumption among parents and children
7. Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.
8. Stress-level glucocorticoids increase fasting hunger and decrease cerebral blood flow in regions regulating eating
9. Lower synaptic density is associated with psychiatric and cognitive alterations in obesity
10. Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder
11. Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey
12. Body Mass Index and Age Effects on Brain 11β-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study
13. Mindfulnes-Based Stress Reduction for Older Couples with Metabolic Syndrome: a Pilot Randomized Controlled Trial
14. Preventing Childhood Obesity Through a Mindfulness-Based Parent Stress Intervention: A Randomized Pilot Study
15. Ending Weight Stigma to Advance Health Equity
16. Naltrexone/bupropion for binge‐eating disorder: A randomized, double‐blind, placebo‐controlled trial
17. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
18. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
19. Reducing BMI below the obesity threshold in adolescents treated with once‐weekly subcutaneous semaglutide 2.4 mg
20. Disordered Eating Behaviors in Emerging Adults With Type 1 Diabetes: A Common Problem for Both Men and Women
21. Championing the use of people‐first language in childhood overweight and obesity to address weight bias and stigma: A joint statement from the European‐Childhood‐Obesity‐Group ( ECOG ), the European‐Coalition‐for‐People‐Living‐with‐Obesity ( ECPO ), the International‐Paediatric‐Association ( IPA ), Obesity‐Canada , the European‐Association‐for‐the‐Study‐of‐Obesity Childhood‐Obesity‐Task‐Force ( EASO‐COTF ), Obesity Action Coalition ( OAC ), The Obesity Society ( TOS ) and the World‐Obesity‐Federation ( WOF )
22. Tirzepatide reduces body weight across body mass index (BMI) categories: A SURMOUNT-1 pre-specified analysis
23. The neurophysiological approach to misophonia: Theory and treatment
24. Functional Connectivity During Exposure to Favorite-Food, Stress, and Neutral-Relaxing Imagery Differs Between Smokers and Nonsmokers
25. New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics
26. When Weight Impacts Health
27. “The Times They Are A-Changin’” at Diabetes Care
28. Weight and Health — Pathophysiology and Therapies
29. Clinical implications of Type 2 diabetes on outcomes after cardiac transplantation
30. Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society
31. Commentary from the American Association of Clinical Endocrinologists on the U.S. Preventive Services Task Force Recommandations Regarding Weight Loss Interventions
32. Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey.
33. Reflecting on a Year at the Helm of Diabetes Care.
34. Tirzepatide Once Weekly for the Treatment of Obesity
35. Parent Stress and Trauma, Autonomic Responses, and Negative Child Behaviors
36. Impact of Obesity on Heart Transplantation Outcomes
37. Treating the Chronic Disease of Obesity
38. Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society.
39. Decreased Sound Tolerance and Tinnitus Retraining Therapy (TRT)
40. The neurophysiologies model for hyperacusis and misophonia.
41. Diagnosis and treatment of misophonia and hyperacusis based on the neurophysiological model.
42. COVID‐19 vaccines are effective in people with obesity: A position statement from The Obesity Society
43. Addressing psychosocial health in the treatment and care of adolescents with obesity
44. Leptin Is Associated With Exaggerated Brain Reward and Emotion Responses to Food Images in Adolescent Obesity
45. Lower synaptic density is associated with psychiatric and cognitive alterations in obesity
46. Dietary supplements and alternative therapies for obesity: A Perspective from The Obesity Society’s Clinical Committee
47. 1014-P: The Impact of Baseline A1C and Admission Glucose on Mortality among Patients with Diabetes Hospitalized with COVID-19
48. WORSE OUTCOMES IN INDIVIDUALS WITH OBESITY UNDERGOING LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION: A LONGITUDINAL INTERMACS STUDY
49. Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19
50. A Single Virtual Consult Reduces Severe Hyperglycemia in Patients Admitted with COVID19 Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.